信息审查对延迟治疗效果随机试验估计和检验的影响。

IF 2 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Jingyi Lin , Yujie Zhao , X. Gregory Chen , Margarita Donica , Larry Léon , Ludovic Trinquart , Shuyan Sabrina Wan
{"title":"信息审查对延迟治疗效果随机试验估计和检验的影响。","authors":"Jingyi Lin ,&nbsp;Yujie Zhao ,&nbsp;X. Gregory Chen ,&nbsp;Margarita Donica ,&nbsp;Larry Léon ,&nbsp;Ludovic Trinquart ,&nbsp;Shuyan Sabrina Wan","doi":"10.1016/j.cct.2025.107860","DOIUrl":null,"url":null,"abstract":"<div><div>Time-to-event endpoints like progression-free survival in oncology randomized trials sometimes demonstrate differential censoring patterns between study arms which can be indicative of informative censoring, depending on censoring reasons. Informative censoring can bias treatment effect estimates but few simulation studies characterized the magnitude of its impact, particularly in the context of therapies with delayed treatment effects. We used copula methods to model dependent censoring data and assessed the impact of informative censoring. To improve the understanding of copula models in this context, we proposed a new measure of the strength of informative censoring, the probability of events being informatively censored. We further proposed a visual tool for examining the underlying correlation pattern between censoring and event time. We conducted simulation studies to assess the impact of informative censoring on estimation bias for hazard ratios, as well as on empirical power of unweighted, weighted log-rank tests, and the MaxCombo test. We implemented data generation algorithm for copula survival models with piece-wise exponential marginals to introduce various censoring patterns under scenarios with delayed treatment effect. We found large overestimation of hazard ratio of the experimental arm versus the control arm and loss in power when there was a positive correlation between event time and censoring time in the control arm and a negative correlation in the experimental arm. When correlations in both arms were of the same direction and degree, we observed minimal impact on hazard ratio estimate and statistical powers.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"152 ","pages":"Article 107860"},"PeriodicalIF":2.0000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact of informative censoring on estimation and testing in randomized trials with delayed treatment effects\",\"authors\":\"Jingyi Lin ,&nbsp;Yujie Zhao ,&nbsp;X. Gregory Chen ,&nbsp;Margarita Donica ,&nbsp;Larry Léon ,&nbsp;Ludovic Trinquart ,&nbsp;Shuyan Sabrina Wan\",\"doi\":\"10.1016/j.cct.2025.107860\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Time-to-event endpoints like progression-free survival in oncology randomized trials sometimes demonstrate differential censoring patterns between study arms which can be indicative of informative censoring, depending on censoring reasons. Informative censoring can bias treatment effect estimates but few simulation studies characterized the magnitude of its impact, particularly in the context of therapies with delayed treatment effects. We used copula methods to model dependent censoring data and assessed the impact of informative censoring. To improve the understanding of copula models in this context, we proposed a new measure of the strength of informative censoring, the probability of events being informatively censored. We further proposed a visual tool for examining the underlying correlation pattern between censoring and event time. We conducted simulation studies to assess the impact of informative censoring on estimation bias for hazard ratios, as well as on empirical power of unweighted, weighted log-rank tests, and the MaxCombo test. We implemented data generation algorithm for copula survival models with piece-wise exponential marginals to introduce various censoring patterns under scenarios with delayed treatment effect. We found large overestimation of hazard ratio of the experimental arm versus the control arm and loss in power when there was a positive correlation between event time and censoring time in the control arm and a negative correlation in the experimental arm. When correlations in both arms were of the same direction and degree, we observed minimal impact on hazard ratio estimate and statistical powers.</div></div>\",\"PeriodicalId\":10636,\"journal\":{\"name\":\"Contemporary clinical trials\",\"volume\":\"152 \",\"pages\":\"Article 107860\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-02-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contemporary clinical trials\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1551714425000540\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425000540","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

肿瘤随机试验中的无进展生存期等时间到事件终点有时在研究组之间显示出不同的审查模式,这可以表明信息审查,取决于审查原因。信息审查可能对治疗效果估计产生偏差,但很少有模拟研究表征其影响的程度,特别是在延迟治疗效果的治疗背景下。我们使用copula方法对相关审查数据进行建模,并评估信息审查的影响。为了在这种情况下提高对copula模型的理解,我们提出了一种新的信息审查强度度量,即事件被信息审查的概率。我们进一步提出了一种可视化工具,用于检查审查和事件时间之间的潜在关联模式。我们进行了模拟研究,以评估信息审查对风险比估计偏差的影响,以及对未加权、加权对数秩检验和MaxCombo检验的经验威力的影响。我们实现了具有分段指数边际的copula生存模型的数据生成算法,以引入延迟处理效果情景下的各种审查模式。我们发现,当控制组的事件时间和审查时间呈正相关,而实验组的事件时间和审查时间呈负相关时,实验组相对于控制组的风险比和功率损失被严重高估。当两个方面的相关性具有相同的方向和程度时,我们观察到对风险比估计和统计能力的影响最小。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of informative censoring on estimation and testing in randomized trials with delayed treatment effects
Time-to-event endpoints like progression-free survival in oncology randomized trials sometimes demonstrate differential censoring patterns between study arms which can be indicative of informative censoring, depending on censoring reasons. Informative censoring can bias treatment effect estimates but few simulation studies characterized the magnitude of its impact, particularly in the context of therapies with delayed treatment effects. We used copula methods to model dependent censoring data and assessed the impact of informative censoring. To improve the understanding of copula models in this context, we proposed a new measure of the strength of informative censoring, the probability of events being informatively censored. We further proposed a visual tool for examining the underlying correlation pattern between censoring and event time. We conducted simulation studies to assess the impact of informative censoring on estimation bias for hazard ratios, as well as on empirical power of unweighted, weighted log-rank tests, and the MaxCombo test. We implemented data generation algorithm for copula survival models with piece-wise exponential marginals to introduce various censoring patterns under scenarios with delayed treatment effect. We found large overestimation of hazard ratio of the experimental arm versus the control arm and loss in power when there was a positive correlation between event time and censoring time in the control arm and a negative correlation in the experimental arm. When correlations in both arms were of the same direction and degree, we observed minimal impact on hazard ratio estimate and statistical powers.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
4.50%
发文量
281
审稿时长
44 days
期刊介绍: Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信